Baillie Gifford - 2SEVENTY BIO INC ownership

2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 129 filers reported holding 2SEVENTY BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of 2SEVENTY BIO INC
ValueSharesWeighting
Q1 2023$2,917
+8.8%
2860.0%0.00%
Q4 2022$2,680
-33.0%
2860.0%0.00%
Q3 2022$4,0000.0%2860.0%0.00%
Q2 2022$4,000
-20.0%
2860.0%0.00%
Q1 2022$5,000
-28.6%
2860.0%0.00%
Q4 2021$7,0002860.00%
Other shareholders
2SEVENTY BIO INC shareholders Q1 2022
NameSharesValueWeighting ↓
Newtyn Management, LLC 1,587,805$27,088,0006.49%
CHI Advisors LLC 819,672$13,984,0005.95%
Madison Avenue Partners, LP 896,972$15,302,342,0002.86%
Bain Capital Life Sciences Investors, LLC 1,408,901$24,036,0002.33%
EcoR1 Capital, LLC 3,495,943$59,641,0001.87%
TANG CAPITAL MANAGEMENT LLC 300,000$5,118,0001.02%
CVI Holdings, LLC 819,672$13,984,0000.92%
ARMISTICE CAPITAL, LLC 2,000,000$34,120,0000.66%
Altium Capital Management LP 115,000$1,962,0000.66%
Casdin Capital, LLC 614,754$10,488,0000.47%
View complete list of 2SEVENTY BIO INC shareholders